The Path from Big Idea to Breakthrough
What does it really take to get that big idea to market? Entrepreneurs Eric Grigsby, MD, MBA, CEO and Founder of Neurovations, and David Caraway, MD PhD, CMO from Nevro […]
Differential Target Multiplexed (DTM™) Spinal Cord Stimulation (SCS) – What is it and how does it work?
CEO and Founder of Neurovations, Dr. Eric Grigsby, and Co-founder and Director of Research at Millennium Pain Center, Dr. Ricardo Vallejo joined up for a deep dive into how a […]
Napa County Partnership Brings Testing to the Vineyard
Rocca Family Vineyards hosts mobile COVID-19 testing in the parking lot.
N3 Laboratories Now Offers Serology (Antibody) Testing for COVID-19
N3 Laboratories is proud to offer Serology (Antibody) testing for COVID-19
Spinal Cord Stimulation with HF10
HF10® is a next-generation spinal cord stimulation (SCS) system offering a wide range of benefits: -HF10 has demonstrated significant relief for both back and leg pain.¹ -HF10 can be left […]
Electrical Activation of Neural Reflexes for the Treatment of Autoimmune Diseases
CEO and Founder of Neurovations Dr. Eric Grigsby and Chief Medical Officer of Setpoint Dr. David Chernoff met for an in-depth discussion on the activation of neuroimmune reflexes by Vagus […]
Are You Addressing Inclusion and Equity in Pain Management?
CEO and Founder of Neurovations, Dr. Eric Grigsby joined Professor and Director of Neuromodulation Services at UCSF, Dr. Lawrence Poree, for an in-depth conversation on equity and inclusion in pain management.
Effectiveness and Safety of Intrathecal Ziconotide: Final Results of the Patient Registry of Intrathecal Ziconotide Management (PRIZM)
The Patient Registry of Intrathecal Ziconotide Management evaluated the long-term effectiveness and safety of intrathecal ziconotide.
Neuromodulation for the COVID-19 Cytokine Storm
CEO and Founder of Neurovations and Eric J. Grigsby, MD, MBA and Peter Staats, MD, MBA met recently for a conversation exploring Neuromodulation for the COVID-19 Cytokine Storm.
Corticosteroid Injections and COVID-19 Infection Risk
Fact: There is low-quality evidence that a single intraarticular corticosteroid injection may increase the risk of contracting the influenza virus.
Preparing Your Re-entry Plan
Download the resources to the webinar and map your future for pain procedures.
The Fight for Survival
How to stay afloat as an independent medical practice during COVID-19 Download the Resources Here Join CalSIPP Board Members Eric J. Grigsby, MD, MBA, and Ruben Kalra, MD, MBA for […]